Status:
RECRUITING
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
Lead Sponsor:
University of California, Berkeley
Conditions:
Sleep Disorder
Circadian Dysregulation
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Mental illness is often chronic, severe, and difficult to treat. Though there has been significant progress towards establishing effective and efficient interventions for psychological health problems...
Detailed Description
Life expectancy has increased drastically in the United States. Longer life is too often associated with illness, discomfort, disability, and dependency. Progress toward promoting health and well-bein...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Aged 50 years and older;
- English language fluency;
- Experiencing a mobility impairment;
- Low income;
- Exhibit a sleep or circadian disturbance as determined by endorsing 4 "quite a bit" or 5 "very much" (or the equivalent for reverse scored items) on one or more PROMIS-SD questions.
- 25-30 on the Montreal Cognitive Assessment, as a negative screen for cognitive impairment.
- Able/willing to give informed consent.
- Exclusion criteria:
- Severe untreated sleep disordered breathing (AHI\>30) or moderate untreated sleep disordered breathing with severe daytime sleepiness (AHI of 15-30 and Epworth Sleepiness Scale \>10);
- Medical conditions that prevent a participant from comprehending and following the basic tenants of treatment (e.g., dementia) or that interfere with sleep in a manner that can't be addressed by a cognitive behavioral treatment (e.g., the Structured Clinical Interview for Sleep Disorders will be used to screen for narcolepsy, REM sleep behavior disorder) or that may preclude full participation (e.g., receipt of end of life care);
- Homelessness;
- Night shift work \>2 nights per week in the past 3 months;
- Substance abuse/dependence only if it makes participation in the study unfeasible;
- Suicide risk sufficient to preclude treatment on an outpatient basis.
Exclusion
Key Trial Info
Start Date :
January 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 28 2028
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT05986604
Start Date
January 4 2024
End Date
July 28 2028
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Berkeley
Berkeley, California, United States, 94720-1650